Acrivon Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $36k | 20k | 1.81 |
| 2025-06-30 | $25k | 21k | 1.19 |
| 2025-03-31 | $66k | 33k | 2.02 |
| 2024-12-31 | $228k | 38k | 5.99 |
| 2024-09-30 | $233k | 33k | 7.00 |
| 2024-06-30 | $127k | 22k | 5.76 |
| 2024-03-31 | $153k | 21k | 7.18 |
| 2023-12-31 | $121k | 25k | 4.94 |
| 2023-09-30 | $135k | 14k | 9.57 |
| 2023-06-30 | $184k | 14k | 12.90 |
| 2023-03-31 | $215k | 17k | 12.66 |
| 2022-12-31 | $41k | 4.1k | 10.00 |